Correction: Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis.

Yin, X; Takov, K; Straube, R; Voit-Bak, K; Graessler, J; Julius, U; Tselmin, S; Rodionov, Roman N; Barbir, M; Walls, M; Theofilatos, K; Mayr, M; Bornstein, S R

Yin, X; Takov, K; Straube, R; Voit-Bak, K; Graessler, J; Julius, U; Tselmin, S; Rodionov, Roman N; Barbir, M; Walls, M; Theofilatos, K; Mayr, M; Bornstein, S R.

Afiliação

Yin X; Kings College London, London, UK.
Takov K; Kings College London, London, UK.
Straube R; Zentrum für Apherese- und Hämofiltration am INUS Tagesklinikum, Cham, Germany.
Voit-Bak K; Zentrum für Apherese- und Hämofiltration am INUS Tagesklinikum, Cham, Germany.
Graessler J; Department and Outpatient Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
Julius U; Department and Outpatient Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
Tselmin S; Department and Outpatient Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
Rodionov RN; Department and Outpatient Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
Barbir M; Royal Brompton Hospital, London, UK.
Walls M; GENinCode, Oxford, UK.
Theofilatos K; Kings College London, London, UK.
Mayr M; Kings College London, London, UK.
Bornstein SR; Technische Universität Dresden, Dresden, Germany.

Horm Metab Res ; 54(4): e3, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35545115

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Horm Metab Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google